Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Fatima, Syeda Sadia ^a   Bozaoglu, Kiymet ^b   Rehman, Rehana ^c   Alam, Faiza ^d   Memon, Abdul Shakoor ^d  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c BAHRIA UNIVERSITY   (Pakistan)

^d JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; GLUCOSE; INSULIN; LIPID;

ADOLESCENT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC GROUP; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OBESITY; PAKISTANI; PHENOTYPE; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; CHEMOKINES; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PAKISTAN; YOUNG ADULT;

EID: 84874515764     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057113     Document Type: Article

References (52)

1. Sorensen TI (2000) The changing lifestyle in the world Body weight and what else? Diabetes Care 23 (Suppl 2) B1-4.
2. Haslam D, James WPT, (2005) Obesity. Lancet 366: 1197-209.
3. Hossain P, Kawar B, Nahas M, (2007) Obesity and diabetes in the developing world-a growing challenge. N Eng J Med 356(3): 213-215.
4. Rosenbaum M, Leibel RL, (1998) The physiology of body weight regulation: relevance to the etiology of obesity in children. Pediatrics 101: 525-39.
5. Asia Pacific Cohort Studies Collaboration national prevalence of obesity, (2007) The burden of overweight and obesity in the Asia-Pacific region. Obesity reviews 8(3): 191-19.
6. National health survey of Pakistan 1990-94 (1997) Health profile of the people of Pakistan Islamabad. PMRC p. 181. Available: http://www.heartfile.org/pdf/NAPmain.pdf. Accessed 2011 Sep 03.
7. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL, (1995) Overweight prevalence and trends for children and adolescents. The national health and nutrition examination surveys 1963 to 1991. Arch Pediatr Adolesc Med 149(10): 1085-91.
8. Jafar TH, Chaturvedi N, Pappas G, (2006) Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. CMAJ 175(9): 1071-7.
9. Wise BE, (2004) The Inflammatory Syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15: 2792-2800.
10. Ford ES, (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 28: 2745-2749.
11. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, et al. (2005) INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366: 1640-1649.
12. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716.
13. Corson MA, (2009) Emerging inflammatory markers for assessing coronary heart disease risk. Curr Cardiol Rep 11(6): 452-9.
14. Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, et al. (2003) Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Letters 555: 495-499.
15. Wittamer V, Bondue B, Guillabert A, Vaasrt G, Parmentier M, et al. (2005) neutrophil-mediated maturation of chemerin a link between innate and adaptive immunity. J Immunol 175: 487-493.
16. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, et al. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 280(41): 34661-34666.
17. Bozaoglu K, Boltan K, Mcmillan J, Zimmet P, Jowett J, et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148: 4687-4694.
18. Goralski KB, Mccarthy T, Hanniman E, Zabel BA, Butcher E, et al. (2007) Chemerin a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 282(38): 28175-28188.
19. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, et al. (2007) Chemerin a new adipokine that modulates adipogenesis via its own receptor. Biochemi Biophys Res Commun 362(4): 1013-1018.
20. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov F, Hong K, et al. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3L1 adipocytes. FEBS Letters 582(5): 573-578.
21. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, et al. (2006) Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol 34: 1021-1032.
22. Stejskal D, Karpisek M, Hanulova Z, Svetak M, (2008) Chemerin is an independent marker of metabolic syndrome in a Caucasian population: a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152(2): 217-221.
23. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, et al. (2010) Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 95(5): 2476-85.
24. WHO Library Cataloguing-in-Publication Data (2008) Waist circumference and Waist Hip Ratio. Report of a WHO expert consultation. Geneva 8-11 available: http://whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf. Accessed 2011 Dec 30.
25. Garrow JS, Webster J, (1985) Quetelet's index (W/H2) as a measure of fatness. Int J Obes 9: 147-53.
26. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6): 499-502.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28(7): 412-419.
28. Snehalatha C, Viswanatha NV, Ramachandran A, (2003) Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 26: 1380-1384.
29. Rosen ED, Spiegelman BM, (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
30. Ronti T, Lupattelli G, Mannarino E, (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol 64: 355-365.
31. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
32. Xu H, Barnes G, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Investig 112(12): 1821-1830.
33. Conde J, Gomez R, Bianco G, Scotece M, Lear P, et al. (2011) Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70(3): 551-9.
34. Gómez R, Conde J, Scotece M, Gómez-Reino JJ, Lago F, et al. (2011) What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 2 7(9): 528-36.
35. Bozaoglu K, Segal D, Sheilds KA, Cummings N, Curran JE, et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican American Population. J Clin Endocrinol Metab 94: 3085-3088.
36. Saremi A, Shavandi N, Parastesh M, Daneshmand H, (2010) Twelve-week aerobic training decreases chemerin level and improves cardio-metabolic risk factors in overweight and obese men. Asian J Sports Med 1(3): 151-158.
37. Dong B, Ji W, Zhang Y, (2011) Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 50: 1093-1097.
38. Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, et al. (2009) Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 58: 1971-1977.
39. Tonjes A, Fasshauer M, Kratzsch J, Stumvoll M, Bluher M, (2010) Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 5(11): e13911.
40. Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, et al. (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61(5): 706-14.
41. Yang M, Yang G, Dong J, Zong H, Liu H, et al. (2010) Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Investig Med 58(7): 883-6.
42. Becker M, Rabe K, Lebherz C, Zugwurst J, Goke B, et al. (2010) Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high fat diet. Diabetes 59: 2898-2903.
43. Yajnik CS, Yudkin JS, (2004) The Y-Y paradox. The Lancet 363(9403): 163 doi:10.1016/S0140-6736(03)15269-5.
44. Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, et al. (2009) Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 58(12): 2731-2740.
45. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, et al. (2010) Chemerin correlates with markers of fatty liver in morbidly obese patients and strongly decreases after weight loss induced by Bariatric surgery. J Clin Endocrinol Metab 95: 2892-2896.
46. Hah YJ, Kim NK, Kim MK, Kim HS, Hur SH, et al. (2011) Relationship between Chemerin levels and cardio metabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease. Diabetes Metab J 35: 248-254.
47. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, et al. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (oxf) 72: 342-348.
48. Landgraf K, Friebe D, Ullrich T, Kratzxch J, Dittrich K, et al. (2012) Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 97(4): E556-64.
49. Lehrke M, Becker A, Greif M, Stark R, Laubender R, et al. (2009) Chemerin is associated with markers of inflammation and components of metabolic syndrome but does not predict coronary insufficiency. Eur J Endocrinol 161: 339-344.
50. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Poul E L, et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 198: 977-985.
51. Kukla M, Berdowska A, Gabriel A, Sawczyn T, Mazur W, et al. (2011) Association between hepatic angiogenesis and serum adipokine profile in non-obese chronic hepatitis C patients. Pol J Pathol 62(4): 218-28.
52. Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, et al. (2010) Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr 74(1): 56-61.